Company news

Becton, Dickinson And Company (NYSE:BDX) news

Becton, Dickinson And Company news releases on 6ix. Latest, Oct 6, 2026: BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

Becton, Dickinson And Company (NYSE:BDX) news

Press releases & updates

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy

Arthur Hu to Join BD as Chief Information and Digital Officer

BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview

BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

BD to Present at Wells Fargo 21st Annual Healthcare Conference

BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

BD Reports Third Quarter Fiscal 2026 Financial Results

Becton Dickinson and : BD Issues Nationwide Recall for Specific Lots of BD® Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

Mike Garrison to Retire from BD

BD to Announce Financial Results for its Third Quarter of Fiscal 2026

Becton Dickinson and : BD Appoints Matthew Sassone as Worldwide President of Pharmacy Automation

BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System

Becton Dickinson and : BD Issues Nationwide Recall for Specific Lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL Applicators Due to Microbial Contamination

BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System

Peter Menziuso Named EVP and President, BD Interventional

BD Appoints Vitor Roque Chief Financial Officer

BD Reports Second Quarter Fiscal 2026 Financial Results

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Rick Byrd to Retire from BD

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight

BD Launches AI-Enabled Medication Dispensing System to the European Market

BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation

Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

BD to Present at Barclays 28th Annual Global Healthcare Conference

BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

Lanesha Minnix Named General Counsel for BD

Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

BD Reports First Quarter Fiscal 2026 Financial Results

BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System